Best Stocks Under $5 Based on a Self-learning Algorithm: Returns up to 326.74% in 1 Year

under 5 Package Name: Stocks Under 5 Dollars
Recommended Positions: Long & Short
Forecast Length: 1 Year (01/10/2018 - 01/10/2019)
I Know First Average: 81.31% (Long) & 30.39% (Short)

Read The Full Forecast

Best Stocks Under $5

Aggressive Stocks Based on Predictive Analytics : Returns up to 184.05% in 1 Year

Package Name: Risk-Conscious - Aggressive Stocks Forecast
Recommended Positions: Long & Short
Forecast Length: 1 Year (01/04/2018 - 01/04/2019)
I Know First Average: 22.86% (Long) & 30.07% (Short)

Read The Full Forecast

Aggressive Stocks

Stocks Under 10 Dollars Based on AI: Returns up to 203.42% in 1 Year

Package Name: Stocks Under 10 Dollars
Recommended Positions: Long & Short
Forecast Length: 1 Year (12/24/2017 - 12/24/2018)
I Know First Average: 49.90% (Long) & 35.76% (Short)

Read The Full Forecast

Stocks Under 10 Dollars

Stocks Under 5 Dollars Based on Big Data Analytics: Returns up to 241.81% in 1 Year

under 5 Package Name: Stocks Under 5 Dollars
Recommended Positions: Long & Short
Forecast Length: 1 Year (12/26/2017 - 12/26/2018)
I Know First Average: 62.51% (Long) & 41.37% (Short)

Read The Full Forecast

Stocks Under 5 Dollars

High Risk High Reward Stocks Based on Artificial Intelligence: Returns up to 189.49% in 1 Year

Package Name: Risk-Conscious - Aggressive Stocks Forecast
Recommended Positions: Long
Forecast Length: 1 Year (12/25/2017 - 12/25/2018)
I Know First Average: 52.01%

Read The Full Forecast

High Risk High Reward Stocks

Winning Stock Forecast: Arrowhead Pharmaceuticals (NASDAQ: ARWR) Returns up to 321.18% in 1 Year

Source https://it.depositphotos.com/3798928/stock-photo-tablets-medicines.html

Since the beginning of 2018 Arrowhead Pharmaceuticals showed growth catalysts for this year. First, according to the quarterly report for the period ended December 31, 2017, on September 28, 2016 the Company entered into a collaboration agreement with Amgen Inc. The Company received a worldwide license for ARO-AMG1, an RNAi therapy for an undisclosed genetically validated cardiovascular target, that makes Amgen wholly responsible for clinical development and commercialization of this technology. Moreover, the

Read More

Best Stocks Under 5 Based on Artificial Intelligence: Returns up to 321.18% in 1 Year

under 5 Package Name: Stocks Under 5 Dollars
Recommended Positions: Long
Forecast Length: 1 Year (12/14/2017 - 12/14/2018)
I Know First Average: 52.22%

Read The Full Forecast

Best Stocks Under 5
Pages:1234567...26»